The morning opened up on a high note for this dually-listed company as it announced U.S. Food and Drug Administration (FDA) approval of its Metronidazole Oral Suspension 500mg/5mL ( ATI-1501 )....

To read the full story on AllPennyStocks.com, click here.

Grafico Azioni Appili Therapeutics (TSX:APLI)
Storico
Da Ago 2024 a Set 2024 Clicca qui per i Grafici di Appili Therapeutics
Grafico Azioni Appili Therapeutics (TSX:APLI)
Storico
Da Set 2023 a Set 2024 Clicca qui per i Grafici di Appili Therapeutics